Education
About Us
Working with TipRanks
Follow Us
Biovie Inc. (BIVI)
:BIVI
BIVI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.57 - $75.00
Previous CloseN/A
Volume1.62M
Average Volume (3M)57.73K
Market Cap
$9.23M
Enterprise Value$1.75M
Total Cash (Recent Filing)$23.15M
Total Debt (Recent Filing)$366.43K
Price to Earnings (P/E)―
Beta2.20
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.95
Shares Outstanding1,860,086
10 Day Avg. Volume57,535
30 Day Avg. Volume57,733
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.19
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-7.62
Enterprise Value/Ebitda-0.10
Forecast
1Y Price Target
$6.00Price Target Upside0.00%
Rating ConsensusModerate Buy
Number of Analyst Covering0
BioVie News
BIVI FAQ
What was Biovie Inc.’s price range in the past 12 months?
Biovie Inc. lowest stock price was $3.57 and its highest was $75.00 in the past 12 months.
What is Biovie Inc.’s market cap?
Biovie Inc.’s market cap is $9.23M.
When is Biovie Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Biovie Inc.’s earnings last quarter?
Biovie Inc. released its earnings results on Feb 14, 2024. The company reported -$0.22 earnings per share for the quarter, beating the consensus estimate of -$0.275 by $0.055.
Is Biovie Inc. overvalued?
According to Wall Street analysts Biovie Inc.’s price is currently same.
Does Biovie Inc. pay dividends?
Biovie Inc. does not currently pay dividends.
What is Biovie Inc.’s EPS estimate?
Biovie Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biovie Inc. have?
Biovie Inc. has 1,860,086 shares outstanding.
What happened to Biovie Inc.’s price movement after its last earnings report?
Biovie Inc. reported an EPS of -$0.22 in its last earnings report, beating expectations of -$0.275. Following the earnings report the stock price went down -0.761%.
Which hedge fund is a major shareholder of Biovie Inc.?
Among the largest hedge funds holding Biovie Inc.’s share is Sheaff Brock Investment Advisors LLC. It holds Biovie Inc.’s shares valued at 0.
BioVie Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$6.00 (0.00% )
$6.00 (0.00% )
Hedge Fund Trend
Decreased
By 513.0 Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days >0.1%
Last 30 Days ▼ 8.4%
Last 30 Days ▼ 8.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-83.07%
12-Months-Change
Fundamentals
Return on Equity
-93.23%
Trailing 12-Months
Asset Growth
-22.39%
Trailing 12-Months
Company Description
Biovie Inc.
BioVie Inc. (BIVI) is a clinical-stage biopharmaceutical company focused on developing innovative therapies for liver disease, specifically targeting unmet medical needs in the treatment of chronic liver disorders and neurological conditions. The company's core products include NE3107, a novel molecule aimed at treating Alzheimer's and Parkinson's diseases, and BIV201, an innovative treatment for ascites due to liver cirrhosis.
Technical Analysis
Ownership Overview
9.31% Insiders
3.98% Mutual Funds
0.39% Other Institutional Investors
83.37% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---